Provider review
Direct Meds review
Sublingual drops for a small dose, at a full-dose monthly price.
There is no low-dose product, so a quarter dose of the drops costs what a full dose does.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
From $249/mo sublingual · $297/mo injection
Visit Direct MedsPrice as published
Direct Meds
From $249/mo sublingual · $297/mo injection
FDA warning letter · Direct Meds · September 2025 · addressed to directmeds.com, Inc. dba DirectMeds. Details in our review.
- Vs median
- $80/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Taking less costs the same here. Direct Meds has no low-dose product, so a small dose of its sublingual semaglutide is billed at the same monthly figure as a full one. What it gets right for this reader is the format. Drops under the tongue make a fraction of a dose easy to measure without drawing a partial unit into a syringe. The monthly price is all-inclusive, with medication, nurse support, shipping and follow-ups in one figure, no membership fee and no long-term commitment, and it ships within a business day of approval. The cost of misreading it is in what is left out. Tirzepatide has no published price, the longer-plan discounts are mentioned but never priced, and neither the dispensing pharmacy nor the states it serves are named.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a needle-free route where a small dose is easy to measure
- You want one monthly figure with nurse support and shipping inside it and no membership fee
- You want to be able to leave without a long-term commitment
Look elsewhere if
- You want to pay less for taking less: the price does not move with the dose
- You want tirzepatide, or a longer-plan discount, priced before you sign up
- You want the dispensing pharmacy and state coverage named on the site
What it actually costs
Price as published
From $249/mo sublingual · $297/mo injection
- Vs median
- $80/mo above the $169 median across the 261 of 407 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
159 of the 407 programs here price a small dose this way. All-inclusive pricing per format with no membership fee, and no low-dose product, so a small dose is a smaller amount inside a standard plan at the standard price. Semaglutide is priced for both the drops and the injection; tirzepatide carries no figure on its public pages.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Optional
- Pricing
- Varies by dose, plan or tier
What it does well
- Sublingual semaglutide drops, so a small dose is measured under the tongue rather than drawn into a syringe
- One all-inclusive monthly price covering medication, nurse support, shipping and follow-ups, with no membership fee
- No long-term commitment, and HSA and FSA cards are accepted
- Ships within one business day of approval, with free priority shipping
- LegitScript-certified, with third-party testing of its medication stated on the site
Pharmacy, labs and oversight
Direct Meds does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is offered but not required. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Direct Meds publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to Direct Meds in September 2025. It is addressed to directmeds.com, Inc. dba DirectMeds — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Direct Meds is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
Direct Meds sells compounded GLP-1s online, with sublingual semaglutide drops placed under the tongue alongside weekly injections of semaglutide and tirzepatide. You answer an online questionnaire, a licensed provider reviews it, usually within a day, and no video appointment is needed. If you are approved, the prescription is compounded at a U.S. pharmacy it does not name and ships within one business day with free priority shipping. The monthly price is all-inclusive: medication, nurse support, shipping and follow-ups, with no membership fee and no long-term commitment. Sublingual semaglutide starts at the lower of its two published figures and injections at the higher; tirzepatide carries no figure on its public pages. Six- and 12-month plans cost less, but those rates are not printed, and it takes HSA and FSA cards. It is LegitScript-certified and says its medication is third-party tested for purity and potency.
The honest cons
No low-dose product: taking less means asking for a smaller dose inside a standard plan at the full monthly price
- No tirzepatide price appears on its public pages, so that molecule cannot be costed before intake
- The longer-plan discounts are mentioned but never priced
- The dispensing pharmacy and the states it serves are not named on the site
- Compounded-only, and compounded GLP-1s are not FDA-approved; evidence for sublingual GLP-1 absorption is thin
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Direct Meds is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Where this sits
#12 of 407
Ordered with the companies that pay us first, and Direct Meds is one of them. A disclosed partition, not a score.
Compare all 407 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- Sublingual troches and drops
- What the evidence actually shows
- Is compounded GLP-1 safe?
- Microdose & reconstitution calculator
- Titration planner
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
$249/mo month to month ($199 on 6-mo)
- Vs median
- $80/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.